Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

By S. Yusuf, F. Zhao, S. Mehta, S. Chrolavicius, G. Tognoni, K. Fox, Clopidogrel in Unstable Angina to Prevent Recurrent Events Tri Investigators. New England Journal of Medicine, 2001

4,160 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/1017a936c5b937841f86b1d00d8c84c8edab2845

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Eric J. Topol
2. Judith Hochman
3. M. Creager

Citations in the corpus

• 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST‐Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update) (2009, background): “(Level of Evidence: A) Aspirin should be initiated on presentation.(158,159) (Level of Evidence: A) Clopidogrel (before or at the time of PCI)(158,159) (Level of Evidence: A) or prasugrel (at the time of PCI)(27) (Level of Evidence: B) is recommended as a second antiplatelet agent.”